Respinid®

Pulmonology

Respinid®

Registration certificate:

INN:

Budesonide

Release form:

Inhalation powder hard capsule

Therapeutic Area:

Pulmonology

Pharmacotherapeutic Group:

Local glucocorticosteroid

Conditions for dispensing:

On prescription

Packaging:

Indications for Use:

The drug is indicated for use in adults and children aged 6 years and older:

Bronchial asthma requiring maintenance therapy with glucocorticosteroids to control the inflammatory process.
Chronic Obstructive Pulmonary Disease (COPD).

Included in the List of Essential Medicines